Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 12;13(5):347.
doi: 10.3390/toxins13050347.

Macrolides: From Toxins to Therapeutics

Kiersten D Lenz  1 , Katja E Klosterman  1 , Harshini Mukundan  1 , Jessica Z Kubicek-Sutherland  1
Affiliations
Review

Macrolides: From Toxins to Therapeutics

Kiersten D Lenz et al. Toxins (Basel). .

Abstract

Macrolides are a diverse class of hydrophobic compounds characterized by a macrocyclic lactone ring and distinguished by variable side chains/groups. Some of the most well characterized macrolides are toxins produced by marine bacteria, sea sponges, and other species. Many marine macrolide toxins act as biomimetic molecules to natural actin-binding proteins, affecting actin polymerization, while other toxins act on different cytoskeletal components. The disruption of natural cytoskeletal processes affects cell motility and cytokinesis, and can result in cellular death. While many macrolides are toxic in nature, others have been shown to display therapeutic properties. Indeed, some of the most well known antibiotic compounds, including erythromycin, are macrolides. In addition to antibiotic properties, macrolides have been shown to display antiviral, antiparasitic, antifungal, and immunosuppressive actions. Here, we review each functional class of macrolides for their common structures, mechanisms of action, pharmacology, and human cellular targets.

Keywords: antibiotic; antifungal; antiparasitic; antiviral; immunosuppressant; macrolide; toxin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhanel G.G., Dueck M., Hoban D.J., Vercaigne L.M., Embil J.M., Gin A.S., Karlowsky J.A. Review of Macrolides and Ketolides. Drugs. 2001;61:443–498. doi: 10.2165/00003495-200161040-00003. - DOI - PubMed
    1. Bryskier A., Bergogne-Bérézin E. Antimicrobial Agents. American Society of Microbiology; Washington, DC, USA: 2005. Macrolides. - DOI
    1. Kanoh S., Rubin B.K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin. Microbiol. Rev. 2010;23:590–615. doi: 10.1128/CMR.00078-09. - DOI - PMC - PubMed
    1. Zhang H., Zou J., Yan X., Chen J., Cao X., Wu J., Liu Y., Wang T. Marine-Derived Macrolides 1990–2020: An Overview of Chemical and Biological Diversity. Mar. Drugs. 2021;19:180. doi: 10.3390/md19040180. - DOI - PMC - PubMed
    1. Guenin-Macé L., Ruf M.-T., Pluschke G., Demangel C. Mycolactone: More than Just a Cytotoxin. In: Pluschke G., Röltgen K., editors. Buruli Ulcer: Mycobacterium Ulcerans Disease. Springer International Publishing; Cham, Switzerland: 2019. pp. 117–134. - DOI

Publication types

MeSH terms

-